.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
Teva
US Department of Justice
McKesson
Johnson and Johnson
Moodys
Colorcon
Cipla
AstraZeneca
Dow

Generated: July 25, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 208194

« Back to Dashboard
NDA 208194 describes BENDEKA, which is a drug marketed by Eagle Pharms and is included in one NDA. It is available from one supplier. There are thirteen patents protecting this drug and one Paragraph IV challenge. Additional details are available on the BENDEKA profile page.

The generic ingredient in BENDEKA is bendamustine hydrochloride. There are twenty-two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the bendamustine hydrochloride profile page.

Summary for NDA: 208194

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Formulation / Manufacturing:see details

Pharmacology for NDA: 208194

Mechanism of ActionAlkylating Activity

Suppliers and Packaging for NDA: 208194

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
BENDEKA
bendamustine hydrochloride
SOLUTION;IV (INFUSION) 208194 NDA Teva Pharmaceuticals USA, Inc. 63459-348 63459-348-04 1 VIAL, MULTI-DOSE in 1 CARTON (63459-348-04) > 4 mL in 1 VIAL, MULTI-DOSE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;IV (INFUSION)Strength100MG/4ML (25MG/ML)
Approval Date:Dec 7, 2015TE:RLD:Yes
Patent:► SubscribePatent Expiration:Jul 12, 2026Product Flag?Substance Flag?Delist Request?Y
Patent:► SubscribePatent Expiration:Jan 28, 2031Product Flag?YSubstance Flag?Delist Request?
Patent:► SubscribePatent Expiration:Jan 28, 2031Product Flag?YSubstance Flag?Delist Request?


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Covington
Merck
Citi
Mallinckrodt
UBS
Daiichi Sankyo
Queensland Health
Federal Trade Commission
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot